- $1.71bn
- $1.34bn
- $45.95m
U.S. STOCKS ON THE MOVE-General Mills, Meta Platforms, Domino's Pizza
U.S. STOCKS ON THE MOVE-Watsco, Septerna, Nike
Brief: Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial
Septerna slumps after scrapping trial of hormonal disorder drug
Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Brief: Septerna-Phase 1 Clinical Trial Ongoing For SEP-786, Oral Small Molecule For Hypoparathyroidism, With Data Expected In Mid-2025
Brief: Septerna Reports Third Quarter 2024 Financial Results And Recent Business Highlights
Brief: Septerna Announces Closing Of $331.2 Million Upsized Initial Public Offering
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut (updated)
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut